Advertisement
Oncology
Subscribe to Oncology
View Sample

FREE Email Newsletter

New Chip Promising for Tumor-Targeting Research

September 22, 2014 10:26 am | by Emil Venere, Purdue University | News | Comments

Researchers have developed a chip capable of simulating a tumor's "microenvironment" and plan to use the new system to test the effectiveness of nanoparticles and drugs that target cancer. The new system, called a tumor-microenvironment-on...

Graphene Sensor Tracks Down Cancer Biomarkers

September 19, 2014 10:51 am | by Institute of Physics | News | Comments

An ultrasensitive biosensor made from the wonder material graphene has been used to detect molecules that indicate an increased risk of developing cancer. The biosensor has been shown to be more than five times more sensitive than bioassay...

Trial Begins for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Biopsies

September 19, 2014 10:08 am | by Worcester Polytechnic Institute | News | Comments

A novel robotic system that can operate inside the bore of an MRI scanner is currently being tested as part of a biomedical research partnership program at Brigham and Women's Hospital in Boston with the aim of determining if the robot, in...

Advertisement

Innovative X-ray Technology – An Option for Improved Breast Cancer Diagnosis

September 19, 2014 8:30 am | by Dr. Thomas Kron, Technical Writer | Articles | Comments

The benefits of mammography for breast cancer screening have been discussed for years. By screening, some say that tumors are discovered earlier, save lives and eliminate the need of having to go through strenuous therapies. Others say that...

Blood Test Could Identify When Cancer Treatment Has Become Detrimental

September 18, 2014 9:53 am | by Institute of Cancer Research | News | Comments

Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop working over time but actually start driving tumor growth, a major new study shows. Researchers identified the emergence of drug-resistant...

New Radiosurgery Technology Provides Highly Accurate Treatment, Greater Patient Comfort

September 17, 2014 11:29 am | by Henry Ford Health System | News | Comments

A new stereotactic radiosurgery system provides the same or a higher level of accuracy in targeting cancer tumors – but offers greater comfort to patients and the ability to treat multiple tumors at once – when compared to other radiation therapy...

New Gene Research Helps Pinpoint Prostate Cancer Risk

September 17, 2014 10:54 am | by Queensland University of Technology | News | Comments

Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-ever analysis of the cancer's genetic biomarkers, reported in Nature Genetics today. QUT Institute of...

Stony Brook Researchers Develop New Method to Measure Cerebral Blood Flow

September 16, 2014 11:49 am | by Stony Brook University | News | Comments

One thing leads to another, especially in research. When Stony Brook University School of Medicine scientists developed a new method to measure how cocaine disrupts blood flow in the brains of mice, doctors and researchers got a way to form a...

Advertisement

Blood Test Could Help Determine Treatment Options for Esophageal Cancer Patients

September 16, 2014 9:30 am | by American Society for Radiation Oncology | News | Comments

A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th...

Predicting Prostate Cancer: Pitt-Developed Test Identifies New Methods for Treatment

September 15, 2014 2:08 pm | by University of Pittsburgh Schools of the Health Sciences | News | Comments

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. The analysis, published today in the American Journal of...

Genetic Testing Can Identify Men at Six-Fold Increased Risk of Prostate Cancer

September 15, 2014 11:58 am | by Institute of Cancer Research | News | Comments

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. The study brings the total number of common genetic...

Fighting Lung Cancer: Faster Image Processing for Low-Radiation CT Scans

September 12, 2014 4:17 pm | by University of Michigan | News | Comments

A new $1.9 million study at the University of Michigan seeks to make low-dose computed tomography scans a viable screening technique by speeding up the image reconstruction from half an hour or more to just five minutes. The advance could be...

ONCOblot Blood Test for Cancer Goes International

September 12, 2014 3:13 pm | by ONCOblot Labs | News | Comments

The ONCOblot Test, a highly sensitive blood test for cancer, has now expanded into international territories; bringing much needed support for early cancer detection to areas beyond The United States. ONCOblot believes that these two new...

Advertisement

VolitionRx NuQ Blood Test Detects 84% of Colorectal Cancers

September 11, 2014 3:38 pm | by PR Newswire | News | Comments

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types, today announced that CEO Cameron Reynolds will this morning present topline data from its 4,800-subject...

IBA and Philips Join Forces to Advance Diagnosis and Treatment of Cancer

September 11, 2014 10:25 am | by LPP | News | Comments

IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy and radiopharmacy solutions, and Royal Philips today announce the signing of a global collaboration to provide advanced diagnostic and therapeutic solutions for...

Monitoring the Response of Bone Metastases to Treatment Using MRI and PET

September 11, 2014 9:50 am | by European Organization for Research and Treatment of Cancer | News | Comments

Imaging technologies are very useful in evaluating a patient's response to cancer treatment, and this can be done quite effectively for most tumors using RECIST, Response Evaluation Criteria in Solid Tumors. However, RECIST works well for...

'Electronic Skin' Could Improve Early Breast Cancer Detection

September 10, 2014 11:23 am | by ACS Applied Materials & Interfaces | News | Comments

For detecting cancer, manual breast exams seem low-tech compared to other methods such as MRI. But scientists are now developing an "electronic skin" that "feels" and images small lumps that fingers can miss. Knowing the size and shape of a lump...

Tiny Medical Technologies from Lemelson-MIT Prize Winning Inventor

September 9, 2014 10:50 am | by Stephanie Martinovich, Lemelson-MIT program | News | Comments

Sangeeta Bhatia SM ’93, PhD ’97, biomedical engineer and professor at MIT, is the recipient of the 2014 $500,000 Lemelson-MIT Prize. Bhatia is recognized for designing and commercializing miniaturized technologies with applications to improve...

Myriad myPath Melanoma Test Reduced Indeterminate Cases by 76 Percent

September 9, 2014 10:16 am | by Myriad Genetics, Inc. | News | Comments

Myriad Genetics, Inc. today presented results from a pivotal clinical utility study of the Myriad myPath Melanoma test at the 2014 College of American Pathologists (CAP) annual meeting in Chicago, Ill. Myriad myPath Melanoma is a novel diagnostic...

Mayo Clinic and IBM Task Watson to Improve Clinical Trial Research

September 8, 2014 1:58 pm | by Mayo Clinic | News | Comments

Mayo Clinic and IBM have announced plans to pilot Watson, the IBM cognitive computer, to match patients more quickly with appropriate clinical trials, beginning with research studies in cancer. A proof-of-concept phase is currently underway...

UV Light-Induced Mutation Drives Many Skin Cancers

September 8, 2014 11:23 am | by Stanford University Medical Center | News | Comments

A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine. The mutation occurs in a gene called KNSTRN, which is involved...

Breath Temperature Test Could Identify Lung Cancer

September 8, 2014 11:05 am | by European Lung Foundation | News | Comments

The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today, suggests that testing the temperature...

Growing Prostate Cancer Organoids in the Lab

September 5, 2014 10:36 am | by Memorial Sloan-Kettering Cancer Center | News | Comments

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test...

A Minimally Invasive, High-Performance Intervention for Staging Lung Cancer

September 5, 2014 10:27 am | by University of Montreal | News | Comments

Endoscopic biopsy of lymph nodes between the two lungs (mediastinum) is a sensitive and accurate technique that can replace mediastinal surgery for staging lung cancer in patients with potentially resectable tumors. Such were the conclusions...

New Blood Test Could Offer More Tailored Treatment of Ovarian Cancer

September 5, 2014 10:01 am | by Manchester University | News | Comments

A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists. Researchers from The University of Manchester and The...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading